Paper41533907
Levodopa Suppresses Choroidal Neovascularization Through a Tyrosinase-Dependent Dual Mechanism.
Veernala I and 5 others. Invest Ophthalmol Vis Sci, 2026. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Levodopa Suppresses Choroidal Neovascularization Through a Tyrosinase-Dependent Dual Mechanism. Papers, record 41533907. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41533907
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Levodopa Suppresses Choroidal Neovascularization Through a Tyrosinase-Dependent Dual Mechanism.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Levodopa | Major topic |
| Monophenol Monooxygenase | Major topic |
| Choroidal Neovascularization | Major topic |
| Animals | |
| Mice | |
| Disease Models, Animal | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Receptors, Dopamine D2 | |
| Receptors, LDL | |
| Dopamine Agonists | |
| Choroid |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 EY034486 | NEI NIH HHS | United States | R01EY034486 | PubMed | NIH RePORTER |
| R01 EY036826 | NEI NIH HHS | United States | R01EY036826 | PubMed | NIH RePORTER |
| P30 CA060553 | NCI NIH HHS | United States | P30CA060553 | PubMed | NIH RePORTER |
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25349810 | Iris color and associated pathological ocular complications: a review of epidemiologic studies. | Int J Ophthalmol | 2014 | https://conductscience.org/library/papers/25349810 | PubMed |
| 2 | 28906084 | Updates on the Epidemiology of Age-Related Macular Degeneration. | Asia Pac J Ophthalmol (Phila) | 2017 | https://conductscience.org/library/papers/28906084 | PubMed |
| 3 | 38965321 | Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020. | Eye (Lond) | 2024 | https://conductscience.org/library/papers/38965321 | PubMed |
| 4 | 32437334 | Retinal microglia are critical for subretinal neovascular formation. | JCI Insight | 2020 | https://conductscience.org/library/papers/32437334 | PubMed |
| 5 | 37440012 | Decoding Race and Age-Related Macular Degeneration: GPR 143 Activity Is the Key. | Adv Exp Med Biol | 2023 | https://conductscience.org/library/papers/37440012 | PubMed |
| 6 | 26974308 | Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1. | Nat Med | 2016 | https://conductscience.org/library/papers/26974308 | PubMed |
| 7 | 33187533 | Ocular macrophage origin and heterogeneity during steady state and experimental choroidal neovascularization. | J Neuroinflammation | 2020 | https://conductscience.org/library/papers/33187533 | PubMed |
| 8 | 26524704 | Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration. | Am J Med | 2016 | https://conductscience.org/library/papers/26524704 | PubMed |
| 9 | 40891775 | Sustained Benefit of Short-Term Levodopa Treatment on Inner Retinal Function in Patients With Diabetes. | Transl Vis Sci Technol | 2025 | https://conductscience.org/library/papers/40891775 | PubMed |
| 10 | 32610682 | Experimental Models in Neovascular Age Related Macular Degeneration. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32610682 | PubMed |
| 11 | 23423728 | The albino mutation of tyrosinase alters ocular angiogenic responsiveness. | Angiogenesis | 2013 | https://conductscience.org/library/papers/23423728 | PubMed |
| 12 | 35396574 | Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis. | Eye (Lond) | 2023 | https://conductscience.org/library/papers/35396574 | PubMed |
| 13 | 26260587 | IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis. | Nat Commun | 2015 | https://conductscience.org/library/papers/26260587 | PubMed |
| 14 | 32276449 | A G-Protein Coupled Receptor and Macular Degeneration. | Cells | 2020 | https://conductscience.org/library/papers/32276449 | PubMed |
| 15 | 12972764 | Mouse model of subretinal neovascularization with choroidal anastomosis. | Retina | 2003 | https://conductscience.org/library/papers/12972764 | PubMed |
| 16 | 36821388 | CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization. | JCI Insight | 2023 | https://conductscience.org/library/papers/36821388 | PubMed |
| 17 | 37572663 | Dopamine signaling from ganglion cells directs layer-specific angiogenesis in the retina. | Curr Biol | 2023 | https://conductscience.org/library/papers/37572663 | PubMed |
| 18 | 37146684 | Levodopa Is Associated with Reduced Development of Neovascular Age-Related Macular Degeneration. | Ophthalmol Retina | 2023 | https://conductscience.org/library/papers/37146684 | PubMed |
| 19 | 32051147 | Novel Detection and Restorative Levodopa Treatment for Preclinical Diabetic Retinopathy. | Diabetes | 2020 | https://conductscience.org/library/papers/32051147 | PubMed |
| 20 | 10967078 | VEGF is major stimulator in model of choroidal neovascularization. | Invest Ophthalmol Vis Sci | 2000 | https://conductscience.org/library/papers/10967078 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42599042 | The Role of Dopaminergic Agonists in Geographic Atrophy: Converging Evidence From Clinical and Experimental Data. | Transl Vis Sci Technol | 2026 | https://conductscience.org/library/papers/42599042 | PubMed |
| 42474422 | L-DOPA Promotes Post-Treatment Neurovascular and Synaptic Homeostasis in Early Diabetic Retinopathy. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42474422 | PubMed |
| 41757060 | L-DOPA treatment promotes sustained neurovascular and synaptic homeostasis in the diabetic retina. | bioRxiv | 2026 | https://conductscience.org/library/papers/41757060 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41533907
GET https://conductscience.org/api/papers/v1/41533907/references?page=2